轩竹生物是国内大型医药集团四环医药（0460.HK）的创新药研究院。汇聚了由海归科学家带领的400余人研发团队，聚焦肿瘤、代谢、消化等前沿领域，致力于1.1类新药的开发。是国内少数同时具备小分子化药、大分子生物药开发及产业化、商业化能力的高新生物医药科技企业。
XuanZhu BioPharma is an original new drug research institute of Sihuan Pharmaceutical(0460.HK),a large domestic pharmaceutical group. The company has converged research and development team with more than 400 people led by oversea scientists. The company is focusing on oncology, metabolism, digestion and other frontier fields, committed to the development of 1.1 type of new drugs. The company is one of few domestic high-tech biomedical technology enterprises consisted with development, industrialization and commercialization capabilities of small molecule drugs and macromolecules.